Related Experiment Video

Updated: May 11, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Synthesis and biological evaluation of sulforaphane derivatives as potential antitumor agents

Kun Hu1, Yan-jie Qi, Juan Zhao

  • 1School of Pharmaceutical Engineering & Life Science, Changzhou University, 1 Gehu Road, Changzhou, Jiangsu 213164, PR China.

European Journal of Medicinal Chemistry
|May 21, 2013
PubMed

Insights

New sulforaphane derivatives show enhanced cancer cell killing abilities and Nrf2 activation compared to sulforaphane (SFN). Derivative 85 is a particularly potent Nrf2 inducer, suggesting potential for improved cancer therapies.

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Sulforaphane (SFN), a natural compound, exhibits anticancer properties.
  • Developing more potent SFN analogs is crucial for advancing cancer treatment strategies.

Purpose of the Study:

  • To synthesize and evaluate novel sulforaphane derivatives for enhanced anticancer activity.
  • To investigate the mechanism of action, including cell cycle arrest, apoptosis, and Nrf2 activation.

Main Methods:

  • Synthesis of sulforaphane derivatives.
  • In vitro cytotoxicity assays against five human cancer cell lines (HepG2, A549, MCF-7, HCT-116, SH-SY5Y).
  • Cell cycle analysis, apoptosis assays, and Western blot for Nrf2 activation.

Main Results:

  • Several synthesized derivatives demonstrated superior cytotoxicity compared to SFN.
  • SFN and derivative 85 induced cell cycle arrest (S or G2/M phase) and apoptosis.
  • Both SFN and derivative 85 activated the Nrf2 transcription factor in a time- and dose-dependent manner.
  • Derivative 85 proved to be a more potent Nrf2 activator than SFN.

Conclusions:

  • The synthesized sulforaphane derivatives possess significant anticancer potential.
  • Derivative 85 shows promising activity as a potent Nrf2 inducer, warranting further investigation for cancer therapy development.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...